P63, a story of mice and men

Journal of Investigative Dermatology

Volumn 131, Issue 6, 2011, Pages 1196-1207

  Vanbokhoven, Hans ^a   Melino, Gerry ^b,c   Candi, Eleonora ^b   Declercq, Wim ^d,e  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN P63; PROTEIN P73;

CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CONGENITAL MALFORMATION; EMBRYO DEVELOPMENT; EPIDERMIS; EPITHELIUM CELL; FAMILY; GENE MUTATION; GENE TARGETING; GENOTYPE; HUMAN; IN VIVO STUDY; KERATINOCYTE; LIMB DEVELOPMENT; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW;

EID: 79956033054     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.84     Document Type: Note

References (114)

1. Acampora D, Merlo GR, Paleari L et al. (1999) Craniofacial, vestibular and bone defects in mice lacking the distal-less-related gene Dlx5. Development 126:3795-809 (Pubitemid 29440478)
2. Adorno M, Cordenonsi M, Montagner M et al. (2009) A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 137:87-98
3. Amiel J, Bougeard G, Francannet C et al. (2001) TP63 gene mutation in ADULT syndrome. Eur J Hum Genet 9:642-5 (Pubitemid 32776382)
4. Beaty TH, Murray JC, Marazita ML et al. (2010) A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4. Nat Genet 42:525-9
5. Bertola DR, Kim CA, Albano LM et al. (2004) Molecular evidence that AEC syndrome and Rapp-Hodgkin syndrome are variable expression of a single genetic disorder. Clin Genet 66:79-80 (Pubitemid 38960826)
6. Birkaya B, Ortt K, Sinha S (2007) Novel in vivo targets of DeltaNp63 in keratinocytes identified by a modified chromatin immunopreci-pitation approach. BMC Mol Biol 8:43
7. Blanpain C, Fuchs E (2009) Epidermal home-ostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 10:207-17
8. Bourdon JC (2007) p53 Family isoforms. Curr Pharm Biotechnol 8:332-6
9. Candi E, Dinsdale D, Rufini A et al. (2007a) TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle 6:274-85
10. Candi E, Rufini A, Terrinoni A et al. (2006a) Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ 13:1037-47
11. Candi E, Rufini A, Terrinoni A et al. (2007b) DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. Proc Natl Acad Sci USA 104:11999-2004 (Pubitemid 47185619)
12. Candi E, Terrinoni A, Rufini A et al. (2006b) p63 is upstream of IKK alpha in epidermal development. J Cell Sci 119:4617-22 (Pubitemid 44964258)
13. Capdevila J, Izpisua Belmonte JC (2001) Patterning mechanisms controlling vertebrate limb development. Annu Rev Cell Dev Biol 17:87-132 (Pubitemid 33096172)
14. Carroll DK, Carroll JS, Leong CO et al. (2006) p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 8:551-61 (Pubitemid 43827347)
15. Celli J, Duijf P, Hamel BC et al. (1999) Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 99:143-53 (Pubitemid 29491781)
16. Cheng W, Jacobs WB, Zhang JJ et al. (2006) DeltaNp63 plays an anti-apoptotic role in ventral bladder development. Development 133:4783-92 (Pubitemid 46063090)
17. Chikh A, Sayan E, Thibaut S et al. (2007) Expression of GATA-3 in epidermis and hair follicle: relationship to p63. Biochem Bio-phys Res Commun 361:1-6 (Pubitemid 47102260)
18. Chitayat D, Babul R, Silver MM et al. (1996) Terminal deletion of the long arm of chromosome 3 [46,XX,del(3)(q27-qter)]. Am J Med Genet 61:45-8
19. Cho MS, Chan IL, Flores ER (2010) DeltaNp63 transcriptionally regulates brachyury, a gene with diverse roles in limb development, tumorigenesis and metastasis. Cell Cycle 9: 2434-41
20. Clements SE, Techanukul T, Holden ST et al. (2010) Rapp-Hodgkin and Hay-Wells ecto-dermal dysplasia syndromes represent a variable spectrum of the same genetic disorder. Br J Dermatol 163:624-9
21. Collavin L, Lunardi A, Del Sal G (2010) p53-family proteins and their regulators: hubs and spokes in tumor suppression. Cell Death Differ 17:901-11
22. Crum CP, McKeon FD (2010) p63 in epithelial survival, germ cell surveillance, and neopla-sia. Annu Rev Pathol 5:349-71
23. De Biase D, Morandi L, Degli Esposti R et al. (2010) p63 short isoforms are found in invasive carcinomas only and not in benign breast conditions. Virchows Arch 456:395-401
24. De Guzman Strong C, Wertz PW, Wang C et al. (2006) Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3. J Cell Biol 175:661-70 (Pubitemid 44790618)
25. De Mollerat XJ, Gurrieri F, Morgan CT et al. (2003) A genomic rearrangement resulting in a tandem duplication is associated with split hand-split foot malformation 3 (SHFM3) at 10q24. Hum Mol Genet 12:1959-71 (Pubitemid 37038805)
26. Del Campo M, Jones MC, Veraksa AN et al. (1999) Monodactylous limbs and abnormal genitalia are associated with hemizygosity for the human 2q31 region that includes the HOXD cluster. Am J Hum Genet 65:104-10 (Pubitemid 30470454)
27. Deyoung MP, Ellisen LW (2007) p63 and p73 in human cancer: defining the network. Onco-gene 26:5169-83 (Pubitemid 47237632)
28. Dianzani I, Garelli E, Gustavsson P et al. (2003) Rapp-Hodgkin and AEC syndromes due to a new frameshift mutation in the TP63 gene. J Med Genet 40:e133
29. Dohn M, Zhang S, Chen X (2001) p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 20:3193-205 (Pubitemid 32553672)
30. Duijf PH, Van Bokhoven H, Brunner HG (2003) Pathogenesis of split-hand/split-foot malformation. Hum Mol Genet 12 Spec No 1:R51-60
31. Duijf PH, Vanmolkot KR, Propping P et al. (2002) Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63. Hum Mol Genet 11:799-804 (Pubitemid 34428647)
32. Faiyaz-Ul-Haque M, Zaidi SH, King LM et al. (2005) Fine mapping of the X-linked split-hand/split-foot malformation (SHFM2) locus to a 5.1-Mb region on Xq26.3 and analysis of candidate genes. Clin Genet 67:93-7
33. Flores ER (2007) The roles of p63 in cancer. Cell Cycle 6:300-4
34. Flores ER, Sengupta S, Miller JB et al. (2005) Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7:363-73 (Pubitemid 40544653)
35. Ghioni P, Bolognese F, Duijf PH et al. (2002) Complex transcriptional effects of p63 iso-forms: identification of novel activation and repression domains. Mol Cell Biol 22:8659-68 (Pubitemid 35397180)
36. Gonfloni S, Di Tella L, Caldarola S et al. (2009) Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat Med 15:1179-85
37. Gressner O, Schilling T, Lorenz K et al. (2005) TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J 24:2458-71 (Pubitemid 41032596)
38. Gritli-Linde A (2010) p63 and IRF6: brothers in arms against cleft palate. J Clin Invest 120:1386-9
39. Guo X, Keyes WM, Papazoglu C et al. (2009) TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat Cell Biol 11:1451-7
40. Helton ES, Zhu J, Chen X (2006) The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63. J Biol Chem 281:2533-42 (Pubitemid 43845713)
41. Hu Y, Baud V, Delhase M et al. (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of Ikap-paB kinase. Science 284:316-20
42. Hu Y, Baud V, Oga T et al. (2001) IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature 410:710-4 (Pubitemid 32290360)
43. Ianakiev P, Kilpatrick MW, Toudjarska I et al. (2000) Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am J Hum Genet 67:59-66 (Pubitemid 30481544)
44. Ihrie RA, Marques MR, Nguyen BT et al. (2005) Perp is a p63-regulated gene essential for epithelial integrity. Cell 120:843-56 (Pubitemid 40568801)
45. Indelman M, Bergman R, Lurie R et al. (2002) A missense mutation in CDH3, encoding P-cadherin, causes hypotrichosis with juvenile macular dystrophy. J Invest Dermatol 119:1210-3 (Pubitemid 35430503)
46. Itin PH (2009) Rationale and background as basis for a new classification of the ectodermal dysplasias. Am J Med Genet A 149A:1973-6
47. Kannu P, Savarirayan R, Ozoemena L et al. (2006) Rapp-Hodgkin ectodermal dysplasia syndrome: the clinical and molecular overlap with Hay-Wells syndrome. Am J Med Genet A 140:887-91
48. Kantaputra PN, Hamada T, Kumchai T et al. (2003) Heterozygous mutation in the SAM domain of p63 underlies Rapp-Hodgkin ectodermal dysplasia. J Dent Res 82:433-7 (Pubitemid 41766007)
49. Kaufman CK, Zhou P, Pasolli HA et al. (2003) GATA-3: an unexpected regulator of cell lineage determination in skin. Genes Dev 17:2108-22 (Pubitemid 37052291)
50. Keyes WM, Vogel H, Koster MI et al. (2006) p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors. Proc Natl Acad Sci USA 103:8435-40 (Pubitemid 43838473)
51. Keyes WM, Wu Y, Vogel H et al. (2005) p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev 19:1986-99 (Pubitemid 41247957)
52. Kjaer KW, Hansen L, Schwabe GC et al. (2005) Distinct CDH3 mutations cause ectodermal dysplasia, ectrodactyly, macular dystrophy (EEM syndrome). J Med Genet 42:292-8 (Pubitemid 40523950)
53. Kondo S, Schutte BC, Richardson RJ et al. (2002) Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet 32:285-9
54. Koster MI, Dai D, Marinari B et al. (2007a) p63 induces key target genes required for epidermal morphogenesis. Proc Natl Acad Sci USA 104:3255-60 (Pubitemid 46364146)
55. Koster MI, Dai D, Roop DR (2007b) Conflicting roles for p63 in skin development and carcinogenesis. Cell Cycle 6:269-73
56. Koster MI, Kim S, Mills AA et al. (2004) p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 18:126-31 (Pubitemid 38141780)
57. Koster MI, Lu SL, White LD et al. (2006) Reactivation of developmentally expressed p63 isoforms predisposes to tumor development and progression. Cancer Res 66:3981-6
58. Koster MI, Marinari B, Payne AS et al. (2009) DeltaNp63 knockdown mice: A mouse model for AEC syndrome. Am J Med Genet A 149A:1942-7
59. Kouwenhoven EN, Van Heeringen SJ, Tena JJ et al. (2010) Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. PLoS Genet 6:e1001065
60. Kurata S, Okuyama T, Osada M et al. (2004) p51/ p63 Controls subunit alpha3 of the major epidermis integrin anchoring the stem cells to the niche. J Biol Chem 279:50069-77 (Pubitemid 39577818)
61. Kurita T, Cunha GR, Robboy SJ et al. (2005) Differential expression of p63 isoforms in female reproductive organs. Mech Dev 122:1043-55 (Pubitemid 41080028)
62. Lang GA, Iwakuma T, Suh YA et al. (2004) Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119:861-72 (Pubitemid 40017691)
63. Lena AM, Shalom-Feuerstein R, di Val Cervo PR et al. (2008) miR-203 represses "stemness" by repressing DeltaNp63. Cell Death Differ 15:1187-95 (Pubitemid 351850972)
64. Leoyklang P, Siriwan P, Shotelersuk V (2006) A mutation of the p63 gene in non-syndromic cleft lip. J Med Genet 43:e28
65. Lin YL, Sengupta S, Gurdziel K et al. (2009) p63 and p73 transcriptionally regulate genes involved in DNA repair. PLoS Genet 5:e1000680
66. Liu C, Nakamura E, Knezevic V et al. (2003) A role for the mesenchymal T-box gene Bra-chyury in AER formation during limb development. Development 130:1327-37 (Pubitemid 36410781)
67. Livera G, Petre-Lazar B, Guerquin MJ et al. (2008) p63 null mutation protects mouse oocytes from radio-induced apoptosis. Reproduction 135:3-12
68. Lo Iacono N, Mantero S, Chiarelli A et al. (2008) Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects. Development 135:1377-88 (Pubitemid 351634259)
69. Mangiulli M, Valletti A, Caratozzolo MF et al. (2009) Identification and functional characterization of two new transcriptional variants of the human p63 gene. Nucleic Acids Res 37:6092-104
70. Marinari B, Ballaro C, Koster MI et al. (2009) IKKalpha is a p63 transcriptional target involved in the pathogenesis of ectodermal dysplasias. J Invest Dermatol 129:60-9
71. McGrath JA, Duijf PH, Doetsch V et al. (2001) Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum Mol Genet 10:221-9 (Pubitemid 32123980)
72. Medawar A, Virolle T, Rostagno P et al. (2008) DeltaNp63 is essential for epidermal commitment of embryonic stem cells. PLoS ONE 3:e3441
73. Mikkola ML (2007) p63 in skin appendage development. Cell Cycle 6:285-90
74. Mikkola ML, Costanzo A, Thesleff I et al. (2010) Treasure or artifact: a decade of p63 research speaks for itself. Cell Death Differ 17:180-3; author reply 4-6
75. Mills AA, Qi Y, Bradley A (2002) Conditional inactivation of p63 by Cre-mediated excision. Genesis 32:138-41 (Pubitemid 34211720)
76. Mills AA, Zheng B, Wang XJ et al. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-13 (Pubitemid 29197649)
77. Moretti F, Marinari B, Lo Iacono N et al. (2010) A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias. J Clin Invest 120:1570-7
78. Muller PA, Caswell PT, Doyle B et al. (2009) Mutant p53 drives invasion by promoting integrin recycling. Cell 139:1327-41
79. Ortt K, Sinha S (2006) Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53. FEBS Lett 580:4544-50 (Pubitemid 44118257)
80. Osada M, Park HL, Nagakawa Y et al. (2005) Differential recognition of response elements determines target gene specificity for p53 and p63. Mol Cell Biol 25:6077-89 (Pubitemid 40946559)
81. Perez CA, Pietenpol JA (2007) Transcriptional programs regulated by p63 in normal epithelium and tumors. Cell Cycle 6:246-54
82. Pollazzon M, Grosso S, Papa FT et al. (2009) A 9.3Mb microdeletion of 3q27.3q29 associated with psychomotor and growth delay, tricuspid valve dysplasia and bifid thumb. Eur J Med Genet 52:131-3
83. Pozzi S, Zambelli F, Merico D et al. (2009) Transcriptional network of p63 in human keratinocytes. PLoS ONE 4:e5008
84. Proksch E, Brandner JM, Jensen JM (2008) The skin: an indispensable barrier. Exp Dermatol 17:1063-72
85. Rahimov F, Marazita ML, Visel A et al. (2008) Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip. Nat Genet 40:1341-7
86. Rinne T, Bolat E, Meijer R et al. (2009) Spectrum of p63 mutations in a selected patient cohort affected with ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (AEC). Am J Med Genet A 149A:1948-51
87. Rinne T, Brunner HG, Van Bokhoven H (2007) p63-associated disorders. Cell Cycle 6:262-8
88. Rinne T, Spadoni E, Kjaer KW et al. (2006) Delineation of the ADULT syndrome pheno-type due to arginine 298 mutations of the p63 gene. Eur J Hum Genet 14:904-10 (Pubitemid 44111627)
89. Robledo RF, Rajan L, Li X et al. (2002) The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes Dev 16:1089-101 (Pubitemid 34507198)
90. Romano RA, Birkaya B, Sinha S (2007) A functional enhancer of keratin14 is a direct transcriptional target of deltaNp63. J Invest Dermatol 127:1175-86 (Pubitemid 46625134)
91. Romano RA, Ortt K, Birkaya B et al. (2009) An active role of the DeltaN isoform of p63 in regulating basal keratin genes K5 and K14 and directing epidermal cell fate. PLoS ONE 4:e5623
92. Romano RA, Smalley K, Liu S et al. (2010) Abnormal hair follicle development and altered cell fate of follicular keratinocytes in transgenic mice expressing DeltaNp63al-pha. Development 137:1431-9
93. Scapoli L, Palmieri A, Martinelli M et al. (2005) Strong evidence of linkage disequilibrium between polymorphisms at the IRF6 locus and nonsyndromic cleft lip with or without cleft palate, in an Italian population. Am J Hum Genet 76:180-3 (Pubitemid 40023778)
94. Scherer SW, Poorkaj P, Allen T et al. (1994) Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3-q22.1. Am J Hum Genet 55:12-20 (Pubitemid 24242377)
95. Schilling T, Kairat A, Melino G et al. (2010) Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma. Biochem Biophys Res Commun 394:817-23
96. Senoo M, Pinto F, Crum CP et al. (2007) p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129:523-36 (Pubitemid 46660965)
97. Shimomura Y, Wajid M, Shapiro L et al. (2008) P-cadherin is a p63 target gene with a crucial role in the developing human limb bud and hair follicle. Development 135:743-53 (Pubitemid 351405027)
98. Simeone A, Acampora D, Pannese M et al. (1994) Cloning and characterization of two members of the vertebrate Dlx gene family. Proc Natl Acad Sci USA 91:2250-4 (Pubitemid 24092081)
99. Stehmeier P, Muller S (2009) Regulation of p53 family members by the ubiquitin-like SUMO system. DNA Repair (Amst) 8:491-8
100. Su X, Chakravarti D, Cho MS et al. (2010) TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467:986-90
101. Su X, Cho MS, Gi YJ et al. (2009a) Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf. EMBO J 28:1904-15
102. Su X, Paris M, Gi YJ et al. (2009b) TAp63 prevents premature aging by promoting adult stem cell maintenance. Cell Stem Cell 5:64-75
103. Suh EK, Yang A, Kettenbach A et al. (2006) p63 protects the female germ line during meiotic arrest. Nature 444:624-8 (Pubitemid 44864440)
104. Testoni B, Borrelli S, Tenedini E et al. (2006) Identification of new p63 targets in human keratinocytes. Cell Cycle 5:2805-11 (Pubitemid 44901743)
105. Thomason HA, Zhou H, Kouwenhoven EN et al. (2010) Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice. J Clin Invest 120:1561-9
106. Truong AB, Kretz M, Ridky TW et al. (2006) p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 20:3185-97 (Pubitemid 44790632)
107. Ugur SA, Tolun A (2008) Homozygous WNT10b mutation and complex inheritance in split-hand/foot malformation. Hum Mol Genet 17:2644-53
108. Van Bokhoven H, Hamel BC, Bamshad M et al. (2001) p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a geno-type-phenotype correlation. Am J Hum Genet 69:481-92 (Pubitemid 32777688)
109. Vigano MA, Lamartine J, Testoni B et al. (2006) New p63 targets in keratinocytes identified by a genome-wide approach. EMBO J 25:5105-16 (Pubitemid 44658528)
110. Wolff S, Talos F, Palacios G et al. (2009) The alpha/beta carboxy-terminal domains of p63 are required for skin and limb development. New insights from the Brdm2 mouse which is not a complete p63 knockout but expresses p63 gamma-like proteins. Cell Death Differ 16:1108-17
111. Yang A, Schweitzer R, Sun D et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714-8 (Pubitemid 29197650)
112. Yang A, Zhu Z, Kapranov P et al. (2006) Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol Cell 24:593-602 (Pubitemid 350284225)
113. Yi R, Poy MN, Stoffel M et al. (2008) A skin microRNA promotes differentiation by repressing "stemness". Nature 452:225-9 (Pubitemid 351380241)
114. Zucchero TM, Cooper ME, Maher BS et al. (2004) Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate. N Engl J Med 351:769-80 (Pubitemid 39095312)